Sacco, Emilio
 Distribuzione geografica
Continente #
EU - Europa 19.961
NA - Nord America 6.500
AS - Asia 4.472
SA - Sud America 945
AF - Africa 154
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 32.068
Nazione #
IT - Italia 13.617
US - Stati Uniti d'America 6.280
SG - Singapore 2.170
DE - Germania 2.003
CN - Cina 1.087
SE - Svezia 1.048
NL - Olanda 773
BR - Brasile 769
FR - Francia 635
UA - Ucraina 475
GB - Regno Unito 330
IN - India 283
IE - Irlanda 263
VN - Vietnam 190
ID - Indonesia 179
RU - Federazione Russa 149
PL - Polonia 148
FI - Finlandia 134
CA - Canada 115
HK - Hong Kong 93
CH - Svizzera 86
JP - Giappone 82
BE - Belgio 72
TR - Turchia 70
AR - Argentina 68
MX - Messico 59
ES - Italia 53
BD - Bangladesh 44
IQ - Iraq 42
ZA - Sudafrica 42
AT - Austria 31
EC - Ecuador 31
CI - Costa d'Avorio 29
KR - Corea 29
IR - Iran 24
MA - Marocco 24
PK - Pakistan 24
CO - Colombia 20
RO - Romania 19
UZ - Uzbekistan 18
VE - Venezuela 18
AL - Albania 17
AU - Australia 17
AZ - Azerbaigian 17
AE - Emirati Arabi Uniti 16
PE - Perù 16
EG - Egitto 14
LT - Lituania 12
CL - Cile 11
CZ - Repubblica Ceca 11
PH - Filippine 11
PT - Portogallo 11
SA - Arabia Saudita 11
HU - Ungheria 10
JO - Giordania 10
TT - Trinidad e Tobago 10
GR - Grecia 9
KE - Kenya 9
MY - Malesia 9
TW - Taiwan 9
EU - Europa 8
LK - Sri Lanka 8
RS - Serbia 7
TH - Thailandia 7
TN - Tunisia 7
CR - Costa Rica 6
PA - Panama 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
JM - Giamaica 5
LU - Lussemburgo 5
NP - Nepal 5
SM - San Marino 5
SN - Senegal 5
UY - Uruguay 5
BH - Bahrain 4
HN - Honduras 4
IL - Israele 4
IS - Islanda 4
KG - Kirghizistan 4
LV - Lettonia 4
NG - Nigeria 4
PY - Paraguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CV - Capo Verde 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
Totale 32.027
Città #
Milan 1.360
Rome 1.201
Chandler 1.173
Singapore 953
Ashburn 661
Naples 383
Jacksonville 274
Dublin 256
Florence 248
Turin 246
Beijing 244
Los Angeles 221
San Mateo 221
Ann Arbor 209
Bologna 198
Palermo 172
Jakarta 167
Bari 163
Wilmington 155
New York 153
Nanjing 145
Catania 122
Munich 116
Genoa 115
Verona 106
Dearborn 101
Hefei 97
Nürnberg 94
São Paulo 94
Frankfurt am Main 90
Hong Kong 89
Bremen 86
Boston 84
Kraków 83
Woodbridge 82
Nanchang 77
Moscow 74
The Dalles 72
Houston 69
Lawrence 69
Princeton 68
Redwood City 68
Brescia 65
Ho Chi Minh City 65
Padova 63
Dallas 62
Brussels 55
Seattle 55
Marseille 54
Hanoi 53
Venice 53
Cagliari 51
Parma 48
Fairfield 47
Taranto 46
Chicago 45
Cattolica 44
Hyderabad 42
Mountain View 42
Bergamo 41
Messina 41
Reggio Emilia 41
Ottawa 40
Perugia 40
Buffalo 38
Pescara 38
Salerno 36
Livorno 35
Tokyo 35
Lancaster 33
Helsinki 32
Redmond 32
Stockholm 32
Kunming 30
Abidjan 29
Düsseldorf 29
Modena 29
Warsaw 29
Kadoma 28
Lucca 28
Trieste 28
Johannesburg 27
Santa Clara 27
Kent 26
London 26
Monza 26
Novara 26
Toronto 26
Amsterdam 25
Tianjin 25
Seoul 24
Atlanta 23
Augusta 23
Belo Horizonte 23
Brooklyn 23
Denver 23
Izmir 22
Montreal 22
Paris 22
Rimini 22
Totale 12.754
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.156
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.181
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 903
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 853
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 558
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 399
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 330
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 304
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 299
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 295
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 229
Le infezioni delle vie urinarie 222
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 215
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 204
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 201
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 181
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 176
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 170
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 170
The occult urothelial cancer 170
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 167
Evidenze microbiologiche in un singolo centro urologico 167
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 166
Male infertility: non-surgical therapy 164
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 159
Hot topics in urological health economics. A mini review 154
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 154
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 154
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 152
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 149
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 148
Imaging in prostate cancer diagnosis: present role and future perspectives 147
[Overactive bladder syndrome: the social and economic perspective] 147
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 147
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 146
Bladder and prostate metastasis from small cell lung cancer: a rare entity 146
Antibiotic prophylaxis in urology 145
Le complicanze nella chirurgia urologica 145
[Foreign bodies in urinary bladder: a clinical case] 144
Brachytherapy in men with prostate cancer: update on indications and outcomes 144
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 142
Microbiological follow-up of nosocomial infections in a single urological center 142
Advanced bladder cancer: New agents and new approaches. A review 141
Imaging in prostate cancer staging: present role e future perspectives 140
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 139
Imaging of renal cell carcinoma: state of the art and recent advances 138
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 137
Advanced bladder cancer: New agents and new approaches. A review 135
Size of Bladder Cancers: Correlation among Different Types of Measurement 135
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 133
Therapeutic strategies in penile cancer: state of the art 133
An introduction to biomaterials in urology 131
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 131
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 129
Inhibition of prostate efferent neurotransmission by amikacin 126
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 126
Imaging in prostate cancer staging: present role and future perspectives 126
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 122
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 122
Circumcision: history, religion and law 121
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 121
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 120
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 120
Local relapse of prostate cancer after primary definitive treatment: the management 119
The occult urothelial cancer 117
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 116
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 114
Current status of robotic urologic surgery in Italy 114
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 114
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 113
Imaging of renal cell carcinoma: state of the art and recent advances 112
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 109
Psychological aptitude for surgery: The importance of non-technical skills 109
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 108
Double J stent migration in the contralateral ureter during robotassisted pyeloplasty: an unique complication 108
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 107
Imaging in prostate cancer diagnosis: present role and future perspectives 107
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 106
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 104
Methylation study of the Paris system for reporting urinary (TPS) categories 104
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 103
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 103
Retigabine induces relaxations of the human bladder detrusor 100
Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review 98
Joint consensus on anesthesia in urologic and gynecologic robotic surgery: Specific issues in management from a task force of the SIAARTI, SIGO, and SIU 98
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 98
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 98
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 97
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 97
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 95
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 93
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 93
Management of Iatrogenic Bladder Injury due to Vascular Surgery: Case Report and Literature Review 93
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 93
2023 WSES guidelines for the prevention, detection, and management of iatrogenic urinary tract injuries (IUTIs) during emergency digestive surgery 93
Cancer and aging: the molecular pathways 92
Imaging of renal cell carcinoma: state of the art and recent advances. 92
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 91
Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis 90
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 90
Totale 28.059
Categoria #
all - tutte 91.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021770 0 0 0 0 0 75 134 78 148 71 199 65
2021/20221.601 164 84 58 144 125 78 59 204 114 114 205 252
2022/20234.654 467 441 313 590 233 476 208 380 529 248 438 331
2023/20246.491 373 667 423 507 478 540 507 607 445 604 602 738
2024/20258.798 607 709 815 652 830 614 646 663 985 686 861 730
2025/20264.985 1.375 399 602 977 1.545 87 0 0 0 0 0 0
Totale 32.298